These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26634024)

  • 1. Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy.
    Sukhovershin RA; Yepuri G; Ghebremariam YT
    Methodist Debakey Cardiovasc J; 2015; 11(3):166-71. PubMed ID: 26634024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.
    Zhang Y; Janssens SP; Wingler K; Schmidt HH; Moens AL
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H634-46. PubMed ID: 21622818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis.
    Godo S; Shimokawa H
    Free Radic Biol Med; 2017 Aug; 109():4-10. PubMed ID: 27988339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide bioavailability dysfunction involves in atherosclerosis.
    Chen JY; Ye ZX; Wang XF; Chang J; Yang MW; Zhong HH; Hong FF; Yang SL
    Biomed Pharmacother; 2018 Jan; 97():423-428. PubMed ID: 29091892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
    Braam B; Verhaar MC
    Curr Pharm Des; 2007; 13(17):1727-40. PubMed ID: 17584103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perillaldehyde prevents the formations of atherosclerotic plaques through recoupling endothelial nitric oxide synthase.
    Yu L; Liu H
    J Cell Biochem; 2018 Dec; 119(12):10204-10215. PubMed ID: 30171746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide, caveolae, and vascular pathology.
    Li XA; Everson W; Smart EJ
    Cardiovasc Toxicol; 2006; 6(1):1-13. PubMed ID: 16845178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-Arginine and vascular health].
    Ströhle A; von Bibra H; Hahn A
    Med Monatsschr Pharm; 2016 Dec; 39(12):515-20. PubMed ID: 29979511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.
    Godo S; Sawada A; Saito H; Ikeda S; Enkhjargal B; Suzuki K; Tanaka S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):97-107. PubMed ID: 26543099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
    Singh JP
    Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries.
    Zhang Y; Zhang W; Edvinsson L; Xu CB
    Eur J Pharmacol; 2014 Feb; 725():10-7. PubMed ID: 24444440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.
    Zhao LY; Li J; Yuan F; Li M; Zhang Q; Huang YY; Pang JY; Zhang B; Sun FY; Sun HS; Li Q; Cao L; Xie Y; Lin YC; Liu J; Tan HM; Wang GL
    Mar Drugs; 2015 Apr; 13(4):2306-26. PubMed ID: 25874925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
    Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
    Liu L; Liu J; Huang Y
    J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoprotective pathways in the vascular endothelium. Do they represent a viable therapeutic target?
    Mason JC
    Vascul Pharmacol; 2016 Nov; 86():41-52. PubMed ID: 27520362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease.
    Papageorgiou N; Androulakis E; Papaioannou S; Antoniades C; Tousoulis D
    Amino Acids; 2015 Sep; 47(9):1741-50. PubMed ID: 26123985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
    Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
    Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.